文献速递妇产影像儿科影像心血管US

胎儿主动脉瓣成形术治疗危重主动脉瓣狭窄的出生后结局

Postnatal outcome following fetal aortic valvuloplasty for critical aortic stenosis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-08-14

单中心回顾性研究纳入2011年1月至2022年6月接受胎儿主动脉瓣成形术的58例危重主动脉瓣狭窄胎儿,技术成功率86.2%,38例(65.5%)活产,28例(48.3%)出生时进入双心室循环路径,其中78.6%在中位随访23.3个月时存活。

要点

  • 胎儿主动脉瓣成形术技术成功定义为球囊扩张主动脉瓣并改善前向血流,本组成功率为86.2%(50/58)。
  • 活产儿中73.7%(28/38)出生时进入双心室循环路径,占研究人群48.3%。
  • 出生时双心室循环者中71.4%(20/28)需新生儿期主动脉瓣成形术,39.3%(11/28)需第二次干预。

核心结论

  • 胎儿主动脉瓣成形术可在86.2%的危重主动脉瓣狭窄胎儿中改善主动脉前向血流,48.3%的胎儿(活产儿的73.7%)出生时达到双心室循环;出生时双心室循环者再干预率高,但78.6%在最近评估时存活。

研究设计与样本

  • 单中心回顾性研究,纳入2011年1月至2022年6月接受胎儿主动脉瓣成形术的58例危重主动脉瓣狭窄胎儿,在超声引导下手术,技术成功基于球囊扩张主动脉瓣并改善前向血流。

诊断标准与关键数值

  • 技术成功定义为球囊扩张主动脉瓣并改善主动脉瓣前向血流,本组技术成功率为86.2%(50/58)。
  • 出生时双心室循环策略基于左心室收缩和舒张功能可保证体循环的假设。
  • 出生时双心室循环者中71.4%(20/28)需主动脉瓣成形术(11例经皮球囊扩张,9例外科手术)。

临床应用与阅片要点

  • 胎儿主动脉瓣成形术可用于改善危重主动脉瓣狭窄胎儿主动脉前向血流,本组86.2%技术成功。
  • 出生时双心室循环者再干预率高,39.3%(11/28)需第二次干预,14.3%(4/28)需第三次干预。
  • 出生时双心室循环者中7.1%(2/28)转为单心室循环。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To report our experience of fetal aortic valvuloplasty (FAV) for critical aortic stenosis (AS), with a focus on the postnatal evolution of the patients.

METHODS: This was a retrospective study including all fetuses with critical AS which underwent FAV in a single center between January 2011 and June 2022. FAV was performed under ultrasound guidance. Technical success was based upon balloon inflation across the aortic valve and improvement of the antegrade aortic flow across the aortic valve. At birth, a biventricular circulation (BVC) strategy was decided assuming the left ventricular (LV) systolic and diastolic function would ensure the systemic circulation.

RESULTS: Sixty-three FAV procedures were performed in 58 fetuses, at a median (range) gestational age of 26.2 (20.3-32.2) weeks. The procedure was technically successful in 50/58 (86.2%) fetuses. There were 11/58 (19.0%) cases of in-utero demise and 9/58 (15.5%) terminations of pregnancy. No patient was liveborn after an unsuccessful procedure. Thirty-eight (65.5%) infants were liveborn, at a median (range) gestational age of 38.1 (29.0-40.6) weeks, of whom 21 (55.3%) required prostaglandin treatment. Twenty-eight of the 38 (73.7%) liveborn children (48.3% of the study population) entered the BVC pathway at birth. Among them, 20 (71.4%) required an aortic valvuloplasty procedure at birth (11 (55.0%) percutaneous balloon, nine (45.0%) surgical) and eight (28.6%) did not require any treatment at birth, but, of these, five (62.5%) underwent surgical valvuloplasty between day 26 and day 1200 of age. Eleven (39.3%) of the infants with BVC at birth required a second intervention and four (14.3%) of them required a third intervention. Two (7.1%) infants who entered the BVC pathway at birth underwent conversion to univentricular circulation (UVC). None of the surviving children with BVC developed pulmonary hypertension. The overall survival rate in those with BVC at birth was 22/28 (78.6%) at a median (range) follow-up of 23.3 (2.0-112.6) months. Ten of the 58 (17.2%) patients had UVC at birth. Among these, six (60.0%) received compassionate care from birth and four (40.0%) underwent surgery. Three of the 10 patients who had UVC at birth were still alive at the latest follow-up assessment, at a median (range) gestational age of 24.3 (8.3-48.7) months.

CONCLUSIONS: FAV for critical AS led to increase of antegrade aortic flow in 86.2% of fetuses, with BVC being achieved in 48.3% (73.7% of the liveborn cases). Among patients with BVC at birth, the rate of reintervention was high, but 78.6% of these children were alive at the latest evaluation. © 2024 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Corroenne R, Meot M, Salomon LJ, et al. Postnatal outcome following fetal aortic valvuloplasty for critical aortic stenosis. Ultrasound Obstet Gynecol. 2024. PMID: 38629579. doi:10.1002/uog.27658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。